Assessment of Nurr1 nucleotide variations in familial Parkinson's disease

Neuroscience Letters

Volumn 366, Issue 2, 2004, Pages 135-138

  Levecque, C ^a   Destee A ^b   Mouroux, V ^a   Amouyel, P ^a   Chartier Harlin, M C ^a  

^a INSTITUT PASTEUR DE LILLE   (France)

^b LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

Association; NR4A2; Nurr1; Parkinson's disease

Indexed keywords

NUCLEAR RECEPTOR RELATED FACTOR 1; NUCLEOTIDE;

ANALYTIC METHOD; ARTICLE; CONTROLLED STUDY; EXON; FAMILIAL DISEASE; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC SCREENING; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN FUNCTION;

AGED; CASE-CONTROL STUDIES; DNA-BINDING PROTEINS; GENOTYPE; HUMANS; MIDDLE AGED; MUTATION; PARKINSONIAN DISORDERS; PEDIGREE; POLYMORPHISM, GENETIC; TRANSCRIPTION FACTORS;

EID: 3242813780     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2004.05.028     Document Type: Article

References (26)

1. Backman C., Perlmann T., Wallen A., Hoffer B.J., Morales M. A selective group of dopaminergic neurons express Nurr1 in the adult mouse brain. Brain Res. 851:1999;125-132
2. Buervenich S., Carmine A., Arvidsson M., Xiang F., Zhang Z., Sydow O., Jonsson E.G., Sedvall G.C., Leonard S., Ross R.G., Freedman R., Chowdari K.V., Nimgaonkar V.L., Perlmann T., Anvret M., Olson L. NURRl mutations in cases of schizophrenia and manic-depressive disorder. Am. J. Med. Genet. 96:2000;808-813
3. Carmine A., Buervenich S., Galter D., Jonsson E.G., Sedvall G.C., Farde L., Gustavsson J.P., Bergman H., Chowdari K.V., Nimgaonkar V.L., Anvret M., Sydow O., Olson L. NURRl promoter polymorphisms: Parkinson's disease, schizophrenia, and personality traits. Am. J. Med. Genet. 120B:2003;51-57
4. Castillo S.O., Baffi J.S., Palkovits M., Goldstein D.S., Kopin I.J., Witta J., Magnuson M.A., Nikodem V.M. Dopamine biosynthesis is selectively abolished in substantia nigra/ventral tegmental area but not in hypothalamic neurons in mice with targeted disruption of the Nurr1 gene. Mol. Cell Neurosci. 11:1998;36-46
5. Chung S., Sonntag K.C., Andersson T., Bjorklund L.M., Park J.J., Kim D.W., Kang U.J., Isacson O., Kim K.S. Genetic engineering of mouse embryonic stem cells by Nurr1 enhances differentiation and maturation into dopaminergic neurons. Eur. J. Neurosci. 16:2002;1829-1838
6. Eells J.B., Rives J.E., Yeung S.K., Nikodem V.M. In vitro regulated expression of tyrosine hydroxylase in ventral midbrain neurons from Nurr1-null mouse pups. J. Neurosci. Res. 64:2001;322-330
7. Elbaz A., Levecque C., Clavel J., Vidal J.S., Richard F., Amouyel P., Alperovitch A., Chartier-Harlin M.C., Tzourio C. CYP2D6 polymorphism, pesticide exposure, and Parkinson's disease. Ann. Neurol. 55:2004;430-434
8. M. Farrer, T. Destee, E. Becquet, V.F. Wavrant-De, V. Mouroux, F. Richard, L. Defebvre, S. Lincoln, J. Hardy, P. Amouyel, M.C. Chartier-Harlin, Linkage exclusion in French families with probable Parkinson's disease, Mov. Disord. 15 (6) 2000 1075-1783.
9. Gelb D.J., Oliver E., Gilman S. Diagnostic criteria for Parkinson disease. Arch. Neurol. 56:1999;33-39
10. Gibb W.R., Lees A.J. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J. Neurol. Neurosurg. Psychiatry. 51:1988;745-752
11. D.J. Healy, P. Sleiman, M.G. Sweeney, L.H. Eunson, N.W. Wood, Exon 1 nurrl gene mutations are rare in familial PD, in: The Movement Disorder Society's, Seventh International Congress of PD and Movement Disorders, 2002 (Ref Type: Abstract).
12. Kim J.H., Auerbach J.M., Rodriguez-Gomez J.A., Velasco I., Gavin D., Lumelsky N., Lee S.H., Nguyen J., Sanchez-Pernaute R., Bankiewicz K., McKay R. Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease. Nature. 418:2002;50-56
13. Le W., Conneely O.M., He Y., Jankovic J., Appel S.H. Reduced Nurr1 expression increases the vulnerability of mesencephalic dopamine neurons to MPTP-induced injury. J. Neurochem. 73:1999;2218-2221
14. Le W., Conneely O.M., Zou L., He Y., Saucedo-Cardenas O., Jankovic J., Mosier D.R., Appel S.H. Selective agenesis of mesencephalic dopaminergic neurons in Nurr1-deficient mice. Exp. Neurol. 159:1999;451-458
15. Le W.D., Xu P., Jankovic J., Jiang H., Appel S.H., Smith R.G., Vassilatis D.K. Mutations in NR4A2 associated with familial Parkinson disease. Nat. Genet. 33:2003;85
16. Levecque C., Elbaz A., Clavel J., Richard F., Vidal J.S., Amouyel P., Tzourio C., Alperovitch A., Chartier-Harlin M.C. Association between Parkinson's disease and polymorphisms in the nNOS and iNOS genes in a community-based case-control study. Hum. Mol. Genet. 12:2003;79-86
17. Rawal N., Periquet M., Durr A., De Michele G., Bonifati V., Teive H.A., Raskin S., Guimaraes J., Agid Y., Brice A. Exclusion of the Nurr1 gene in autosomal recessive Parkinson's disease. J. Neurol. 249:2002;1127-1129
18. Sakurada K., Ohshima-Sakurada M., Palmer T.D., Gage F.H. Nurr1, an orphan nuclear receptor, is a transcriptional activator of endogenous tyrosine hydroxylase in neural progenitor cells derived from the adult brain. Development. 126:1999;4017-4026
19. Saucedo-Cardenas O., Quintana-Hau J.D., Le W.D., Smidt M.P., Cox J.J., De Mayo F., Burbach J.P., Conneely O.M. Nurr1 is essential for the induction of the dopaminergic phenotype and the survival of ventral mesencephalic late dopaminergic precursor neurons. Proc. Natl. Acad. Sci. USA. 95:1998;4013-4018
20. Tan E.K., Chung H., Zhao Y., Shen H., Chandran V.R., Tan C., Teoh M., Yih Y., Pavanni R., Wong M.C. Genetic analysis of Nurr1 haplotypes in Parkinson's disease. Neurosci. Lett. 347:2003;139-142
21. Tregouet D.A., Barbaux S., Escolano S., Tahri N., Golmard J.L., Tiret L., Cambien F. Specific haplotypes of the P-selectin gene are associated with myocardial infarction. Hum. Mol. Genet. 11:2002;2015-2023
22. Wellenbrock C., Hedrich K., Schafer N., Kasten M., Jacobs H., Schwinger E., Hagenah J., Pramstaller P.P., Vieregge P., Klein C. NR4A2 mutations are rare among European patients with familial Parkinson's disease. Ann. Neurol. 54:2003;415
23. Xu P.Y., Liang R., Jankovic J., Hunter C., Zeng Y.X., Ashizawa T., Lai D., Le W.D. Association of homozygous 7048G7049 variant in the intron six of Nurr1 gene with Parkinson's disease. Neurology. 58:2002;881-884
24. Zetterstrom R.H., Williams R., Perlmann T., Olson L. Cellular expression of the immediate early transcription factors Nurr1 and NGFI-B suggests a gene regulatory role in several brain regions including the nigrostriatal dopamine system. Brain Res. Mol. Brain Res. 41:1996;111-120
25. Zheng K., Heydari B., Simon D.K. A common NURRl polymorphism associated with Parkinson disease and diffuse Lewy body disease. Arch. Neurol. 60:2003;722-725
26. Zimprich A., Asmus F., Leitner P., Castro M., Bereznai B., Homann N., Ott E., Rutgers A.W., Wieditz G., Trenkwalder C., Gasser T. Point mutations in exon 1 of the NR4A2 gene are not a major cause of familial Parkinson's disease. Neurogenetics. 4:2003;219-220